QS Investors’s Mesa Laboratories MLAB Stock Holding History

QS Investors’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-600	Closed	-$131K	–	1396
2020 Q2	$131K	Buy	+600	New	+$138K	﹤0.01%	1243

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

QS Investors's MLAB Position: Q3 2020 in Review

QS Investors sold out of Mesa Laboratories (MLAB) in Q3 2020, closing a stake of 600 shares — an estimated $131K sold.

QS Investors first reported a position in MLAB in Q2 2020 and held it in 1 quarter. The position peaked at $131K in Q2 2020. 153 funds tracked by Wall St. Rank hold MLAB as of Q3 2020.

QS Investors reported no remaining Mesa Laboratories position as of Q3 2020 after selling out during the quarter.
QS Investors sold 600 Mesa Laboratories shares in Q3 2020, an estimated $131K.
QS Investors first reported a position in Mesa Laboratories in Q2 2020 and held it in 1 quarter.
QS Investors's Mesa Laboratories position peaked at $131K in Q2 2020.
153 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.